RT-210

N/A

Report date: 2025/01/26 15:39:02

Base Information

Drug NameRT-210
Drug Alias NameRT-210
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsObesityMetabolic SyndromeDiabetes Mellitus, Type 2 +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRenova Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRenova Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsObesityMetabolic SyndromeDiabetes Mellitus, Type 2 +[4
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A